{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T09:03:40Z","timestamp":1789981420815,"version":"4.0.1"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T00:00:00Z","timestamp":1782345600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T00:00:00Z","timestamp":1782345600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1007\/s00210-026-05596-z","type":"journal-article","created":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T00:21:54Z","timestamp":1782346914000},"page":"19429-19441","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Timing and severity of acute kidney injury in hospitalized adults receiving vancomycin plus NKCC inhibitor with or without piperacillin\u2013tazobactam"],"prefix":"10.1007","volume":"399","author":[{"given":"Azfar Athar","family":"Ishaqui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rina","family":"Tripathi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pankaj","family":"Tripathi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saad S.","family":"Alqahtani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hafiz A.","family":"Makeen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khalid","family":"Orayj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,25]]},"reference":[{"key":"5596_CR1","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1007\/s40620-025-02234-4","volume":"38","author":"E Adiyeke","year":"2025","unstructured":"Adiyeke E, Ren Y, Fogel S, Rashidi P, Segal M, Shenkman EA, Bihorac A, Ozrazgat-Baslanti T (2025) Epidemiology, trajectories and outcomes of acute kidney injury among hospitalized patients: a large retrospective multicenter cohort study. J Nephrol 38:1673\u20131682","journal-title":"J Nephrol"},{"key":"5596_CR2","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s12879-024-10227-0","volume":"25","author":"AM Alshehri","year":"2025","unstructured":"Alshehri AM, Al Yami MS, Aldairem A, Alfehaid L, Almutairi AR, Almohammed OA, Badawoud AM (2025) Evaluating the risk of acute kidney injury and mortality associated with concomitant use of vancomycin with piperacillin\/tazobactam or meropenem in critically ill and non-critically ill patients: a systematic review and meta-analysis. BMC Infect Dis 25:36","journal-title":"BMC Infect Dis"},{"key":"5596_CR3","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1016\/j.cmi.2020.03.019","volume":"26","author":"I Bellos","year":"2020","unstructured":"Bellos I, Karageorgiou V, Pergialiotis V, Perrea D (2020) Acute kidney injury following the concurrent administration of antipseudomonal \u03b2-lactams and vancomycin: a network meta-analysis. Clin Microbiol Infect 26:696\u2013705","journal-title":"Clin Microbiol Infect"},{"key":"5596_CR4","doi-asserted-by":"publisher","first-page":"e215","DOI":"10.1161\/01.CIR.101.23.e215","volume":"101","author":"AL Goldberger","year":"2000","unstructured":"Goldberger AL, Amaral LA, Glass L, Hausdorff JM, Ivanov PC, Mark RG, Mietus JE, Moody GB, Peng C-K, Stanley HE (2000) PhysioBank, PhysioToolkit, and PhysioNet: components of a new research resource for complex physiologic signals. Circulation 101:e215\u2013e220","journal-title":"Circulation"},{"key":"5596_CR5","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1093\/cid\/ciw811","volume":"64","author":"DA Hammond","year":"2017","unstructured":"Hammond DA, Smith MN, Li C, Hayes SM, Lusardi K, Bookstaver PB (2017) Systematic review and metaanalysis of acute kidney injury associated with concomitant vancomycin and piperacillin\/tazobactam. Clin Infect Dis 64:666\u2013674","journal-title":"Clin Infect Dis"},{"key":"5596_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41597-022-01899-x","volume":"10","author":"AE Johnson","year":"2023","unstructured":"Johnson AE, Bulgarelli L, Shen L, Gayles A, Shammout A, Horng S, Pollard TJ, Hao S, Moody B, Gow B (2023) MIMIC-IV, a freely accessible electronic health record dataset. Scientific Data 10:1","journal-title":"Scientific Data"},{"key":"5596_CR7","doi-asserted-by":"publisher","unstructured":"Johnson A, Bulgarelli L, Pollard T, Gow B, Moody B, Horng S, Celi LA, Mark R (2024) MIMIC-IV (version 3.1). PhysioNet. https:\/\/doi.org\/10.13026\/kpb9-mt58","DOI":"10.13026\/kpb9-mt58"},{"key":"5596_CR8","doi-asserted-by":"publisher","first-page":"2052","DOI":"10.3390\/ijms23042052","volume":"23","author":"W-C Kan","year":"2022","unstructured":"Kan W-C, Chen Y-C, Wu V-C, Shiao C-C (2022) Vancomycin-associated acute kidney injury: a narrative review from pathophysiology to clinical application. Int J Mol Sci 23:2052","journal-title":"Int J Mol Sci"},{"key":"5596_CR9","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1007\/s40264-019-00846-x","volume":"42","author":"SL Kane-Gill","year":"2019","unstructured":"Kane-Gill SL, Ostermann M, Shi J, Joyce EL, Kellum JA (2019) Evaluating renal stress using pharmacokinetic urinary biomarker data in critically ill patients receiving vancomycin and\/or piperacillin\u2013tazobactam: a secondary analysis of the multicenter sapphire study. Drug Saf 42:1149\u20131155","journal-title":"Drug Saf"},{"key":"5596_CR10","doi-asserted-by":"publisher","first-page":"3743","DOI":"10.1128\/AAC.03011-15","volume":"60","author":"S Karino","year":"2016","unstructured":"Karino S, Kaye KS, Navalkele B, Nishan B, Salim M, Solanki S, Pervaiz A, Tashtoush N, Shaikh H, Koppula S (2016) Epidemiology of acute kidney injury among patients receiving concomitant vancomycin and piperacillin-tazobactam: opportunities for antimicrobial stewardship. Antimicrob Agents Chemother 60:3743\u20133750","journal-title":"Antimicrob Agents Chemother"},{"key":"5596_CR11","unstructured":"Kellum JA, Lameire N, Aspelin P, Barsoum RS, Burdmann EA, Goldstein SL, Herzog CA, Joannidis M, Kribben A, Levey AS (2012) Kidney disease: improving global outcomes (KDIGO) acute kidney injury work group. KDIGO clinical practice guideline for acute kidney injury. Kidney Int Suppl\u00a02:1\u2013138"},{"key":"5596_CR12","doi-asserted-by":"publisher","first-page":"3977","DOI":"10.1111\/bcp.15429","volume":"88","author":"JY Kim","year":"2022","unstructured":"Kim JY, Yee J, Yoon HY, Han JM, Gwak HS (2022) Risk factors for vancomycin-associated acute kidney injury: a systematic review and meta-analysis. Br J Clin Pharmacol 88:3977\u20133989","journal-title":"Br J Clin Pharmacol"},{"key":"5596_CR13","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s11908-024-00829-9","volume":"26","author":"S Lee","year":"2024","unstructured":"Lee S, Heil E (2024) The verdict on vancomycin and piperacillin\/tazobactam-associated nephrotoxicity: acquittal by biomarkers or guilty as charged? Current Infectious Disease Reports 26:39\u201346","journal-title":"Current Infectious Disease Reports"},{"key":"5596_CR14","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1097\/CCM.0000000000002769","volume":"46","author":"MK Luther","year":"2018","unstructured":"Luther MK, Timbrook TT, Caffrey AR, Dosa D, Lodise TP, LaPlante KL (2018) Vancomycin plus piperacillin-tazobactam and acute kidney injury in adults: a systematic review and meta-analysis. Crit Care Med 46:12\u201320","journal-title":"Crit Care Med"},{"key":"5596_CR15","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1093\/cid\/ciw709","volume":"64","author":"B Navalkele","year":"2017","unstructured":"Navalkele B, Pogue JM, Karino S, Nishan B, Salim M, Solanki S, Pervaiz A, Tashtoush N, Shaikh H, Koppula S (2017) Risk of acute kidney injury in patients on concomitant vancomycin and piperacillin\u2013tazobactam compared to those on vancomycin and cefepime. Clin Infect Dis 64:116\u2013123","journal-title":"Clin Infect Dis"},{"key":"5596_CR16","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1093\/jac\/dkae410","volume":"80","author":"K Pan","year":"2025","unstructured":"Pan K, Li R, Li Y, Ding X, Li X, Lv Q (2025) Vancomycin combined with piperacillin\/tazobactam increases the risk of acute kidney injury compared with vancomycin plus other anti-pseudomonal beta-lactams: a systematic review and network meta-analysis. J Antimicrob Chemother 80:47\u201358","journal-title":"J Antimicrob Chemother"},{"key":"5596_CR17","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1007\/s00134-021-06454-7","volume":"47","author":"P Pickkers","year":"2021","unstructured":"Pickkers P, Darmon M, Hoste E, Joannidis M, Legrand M, Ostermann M, Prowle JR, Schneider A, Schetz M (2021) Acute kidney injury in the critically ill: an updated review on pathophysiology and management. Intensive Care Med 47:835\u2013850","journal-title":"Intensive Care Med"},{"key":"5596_CR18","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1001\/jama.2023.20583","volume":"330","author":"ET Qian","year":"2023","unstructured":"Qian ET, Casey JD, Wright A, Wang L, Shotwell MS, Siemann JK, Dear ML, Stollings JL, Lloyd BD, Marvi TK (2023) Cefepime vs piperacillin-tazobactam in adults hospitalized with acute infection: the ACORN randomized clinical trial. JAMA 330:1557\u20131567","journal-title":"JAMA"},{"key":"5596_CR19","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1093\/cid\/ciy724","volume":"68","author":"DJ Schreier","year":"2019","unstructured":"Schreier DJ, Kashani KB, Sakhuja A, Mara KC, Tootooni MS, Personett HA, Nelson S, Rule AD, Steckelberg JM, Tande AJ (2019) Incidence of acute kidney injury among critically ill patients with brief empiric use of antipseudomonal \u03b2-lactams with vancomycin. Clin Infect Dis 68:1456\u20131462","journal-title":"Clin Infect Dis"},{"key":"5596_CR20","doi-asserted-by":"publisher","DOI":"10.3389\/fneph.2022.995358","volume":"2","author":"K Whitenack","year":"2022","unstructured":"Whitenack K, Behal ML, Thompson Bastin ML, Aycinena JC, Adams PM, Flannery AH (2022) Progression of kidney injury with the combination of vancomycin and piperacillin-tazobactam or cefepime in sepsis-associated acute kidney injury. Frontiers in Nephrology 2:995358","journal-title":"Frontiers in Nephrology"},{"key":"5596_CR21","doi-asserted-by":"publisher","first-page":"3665","DOI":"10.3390\/jcm11133665","volume":"11","author":"L Zhou","year":"2022","unstructured":"Zhou L, Li Y, Gao Q, Lin Y, Su L, Chen R, Cao Y, Xu R, Luo F, Gao P (2022) Loop diuretics are associated with increased risk of hospital-acquired acute kidney injury in adult patients: a retrospective study. J Clin Med 11:3665","journal-title":"J Clin Med"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-026-05596-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-026-05596-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-026-05596-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T08:10:59Z","timestamp":1789978259000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-026-05596-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,25]]},"references-count":21,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["5596"],"URL":"https:\/\/doi.org\/10.1007\/s00210-026-05596-z","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,25]]},"assertion":[{"value":"4 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study used the de-identified PhysioNet MIMIC-IV dataset of hospitalized adults. The informed consent was waived due to the retrospective design.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors have agreed to the publication of this study.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":4,"name":"Ethics","label":"Clinical trial number","group":{"name":"EthicsHeading","label":"Declarations"}}]}}